One-year study evaluating efficacy of an iodine-restricted diet for the treatment of moderate-to-severe hyperthyroidism in cats

被引:8
|
作者
Loftus, John P. [1 ]
DeRosa, Sage [1 ]
Struble, Angela M. [1 ]
Randolph, John F. [1 ]
Wakshlag, Joseph J. [1 ]
机构
[1] Cornell Univ, Coll Vet Med, Dept Clin Sci, Ithaca, NY 14853 USA
关键词
feline; thyroxine; free T4; nuclear scintigraphy; iodine; FELINE; FOOD; MANAGEMENT; DISEASE; SCORE;
D O I
10.2147/VMRR.S189709
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Purpose: This study sought to determine the efficacy of a therapeutic iodine-restricted diet during a 12 -month interval in cats with moderately to severely increased total thyroxine (TT4) concentrations. Patients and methods: Eight hyperthyroid cats with serum creatinine <2.0 mg/dL and TT4 >6.0 mu g/dL (reference interval 1.5-4.0 mu g/dL) were enrolled. Each cat underwent an initial physical examination, complete blood count, serum chemistry panel, thyroid profile, thyroid scintigraphy, and echocardiogram. Physical examination and all blood samplings were repeated at 1, 2, 3, 6, and 12 months after enrollment. Clients were instructed to feed only the therapeutic iodine-restricted diet throughout the entire study. Results: Median TT4 was 8.4 (range 6.2-24.0) mu g/dL at study onset. Thyroid scintigraphy was abnormal in all cats, confirming hyperthyroidism. Six out of eight cats had normal serum TT4 after 4 weeks of feeding the therapeutic diet. The two cats that did not achieve normalization of TT4 at 4 weeks had the highest initial TT4 concentrations. Three cats were withdrawn from the study due to emergence of chronic kidney disease. Conclusion: An iodine-restricted diet was able to control moderate-to-severe hyperthyroidism in most (six out of eight) of the cats by 4 weeks. Cats with highest baseline TT4 took substantially longer before TT4 concentrations normalized, if at all.
引用
收藏
页码:9 / 16
页数:8
相关论文
共 50 条
  • [1] Effect of Feeding an Iodine-Restricted Diet in Cats with Spontaneous Hyperthyroidism
    Hui, T. Y.
    Bruyette, D. S.
    Moore, G. E.
    Scott-Moncrieff, J. C.
    [J]. JOURNAL OF VETERINARY INTERNAL MEDICINE, 2015, 29 (04): : 1063 - 1068
  • [2] One-Year Safety and Efficacy Study of Arformoterol Tartrate in Patients With Moderate to Severe COPD
    Donohue, James F.
    Hanania, Nicola A.
    Make, Barry
    Miles, Matthew C.
    Mahler, Donald A.
    Curry, Lisa
    Tosiello, Robert
    Wheeler, Alistair
    Tashkin, Donald P.
    [J]. CHEST, 2014, 146 (06) : 1531 - 1542
  • [3] EFFICACY AND SAFETY OF ORAL FEBUXOSTAT IN SUBJECTS WITH MODERATE-TO-SEVERE CHRONIC KIDNEY DISEASE (CKD): ONE-YEAR RESULTS
    Filiopoulos, Vassilis
    Manolios, Nikolaos
    Hadjiyannakos, Dimitrios
    Arvanitis, Dimitrios
    Panagiotopoulos, Konstantinos
    Vlassopoulos, Dimosthenis
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 : 370 - 370
  • [4] Evaluating the safety and efficacy of baricitinib for the treatment of moderate-to-severe atopic dermatitis
    Bridgeman, Sarah G.
    Martino, Anna K.
    Strowd, Lindsay C.
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2023, 24 (18) : 2153 - 2159
  • [5] One-Year, Multicenter, Open-Label, Single-Arm Study Evaluating the Safety and Effectiveness of Etanercept for the Treatment of Moderate-to-Severe Plaque Psoriasis in a Canadian Population
    Vender, Ronald
    Lynde, Charles
    Gilbert, Martin
    Ho, Vincent
    Sapra, Sheetal
    Poulin-Costello, Melanie
    [J]. JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2013, 17 (02) : 129 - 138
  • [6] Treatment of Moderate-to-Severe Psoriasis With Alefacept for Up to One Year:A Case Series
    Shah, Avnee
    ONeill, Jenna
    Feldman, Steven R.
    [J]. JOURNAL OF DRUGS IN DERMATOLOGY, 2010, 9 (12) : 1491 - 1494
  • [7] Impact of adalimumab on disease burden in moderate-to-severe ulcerative colitis patients: The one-year, real-world UCanADA study
    Talat Bessissow
    Geoffrey C Nguyen
    Osman Tarabain
    Laurent Peyrin-Biroulet
    Nathalie Foucault
    Kevin Mc Hugh
    Joannie Ruel
    [J]. World Journal of Gastroenterology, 2022, 28 (34) : 5058 - 5075
  • [8] Impact of adalimumab on disease burden in moderate-to-severe ulcerative colitis patients: The one-year, real-world UCanADA study
    Bessissow, Talat
    Nguyen, Geoffrey C.
    Tarabain, Osman
    Peyrin-Biroulet, Laurent
    Foucault, Nathalie
    McHugh, Kevin
    Ruel, Joannie
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2022, 28 (34) : 5058 - 5075
  • [9] One-year safety and efficacy of ustekinumab and results of dose adjustment after switching from inadequate methotrexate treatment: the TRANSIT randomized trial in moderate-to-severe plaque psoriasis
    Reich, K.
    Puig, L.
    Paul, C.
    Kragballe, K.
    Luger, T.
    Lambert, J.
    Chimenti, S.
    Girolomoni, G.
    Nicolas, J. -F.
    Rizova, E.
    Brunori, M.
    Mistry, S.
    Bergmans, P.
    Barker, J.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2014, 170 (02) : 435 - 444
  • [10] The effect of methimazole pretreatment on the efficacy of radioactive iodine therapy in Graves' hyperthyroidism: One-year follow-up of a prospective, randomized study
    Andrade, VA
    Gross, JL
    Maia, AL
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (08): : 3488 - 3493